Ten normal volunteers and 45 patients with breast abnormalities were examined with magnetic resonance (MR), utilizing a 0.3-tesla superconducting magnet. In all patients, MR detected an abnormality that corresponded to the area of pathology seen on either a mammogram or computed tomographic (CT) scan. An appreciable advantage of MR over mammography was observed in patients with cysts and in those with areas of asymmetric dysplastic breast tissue. Abnormalities on MR images appeared as areas of low signal intensity relative to adjacent normal ductal and fatty tissue. The configuration of a lesion on MR permitted distinction between a benign and a malignant process.
Clinical and mammographic data of 1009 consecutive patients were correlated with histopathologic data of 1144 biopsy specimens of nonpalpable breast lesions to better define the presentation and biologic behavior of early breast cancer. Patients with malignant neoplasms (269 [24%] of 1144 specimens) were older (mean age, 62.1 years) than patients with benign lesions (mean age, 54.9 years). Furthermore, patients with invasive disease were older (mean age, 63.3 years) than patients with noninvasive disease (mean age, 58.5 years) with an overall increased risk of invasive cancer per year of 1.035. A 58% incidence of invasive cancer was detected for lesions characterized by calcifications, while the incidence of invasive cancer was 84% for isolated mass lesions (relative risk, 4.31 for masses). Isolated mammographic calcifications associated with cancer appeared in a younger population and were significantly associated with noninvasive ductal cancer. Breast cancer presenting as a mammographic mass appeared in an older group and was highly associated with the presence of invasive disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.